Skip to search formSkip to main contentSkip to account menu

gemcitabine triphosphate

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2011
Highly Cited
2011
PurposeTo develop a sensitive analytical method to quantify gemcitabine (2′,2′-difluorodeoxycytidine, dFdC) and its metabolites 2… 
Highly Cited
2008
Highly Cited
2008
Purpose: To determine the toxicity, tolerability, pharmacokinetics, pharmacodynamics, and preliminary antitumor activity of oral… 
Highly Cited
2006
Highly Cited
2006
Gemcitabine triphosphate (dFdCTP) is a highly active metabolite of gemcitabine. It is formed intra-cellularly via the… 
Review
2004
Review
2004
SummaryGemcitabine is a nucleoside analogue with excellent clinical activity against solid tumors. Within the cell, gemcitabine… 
Review
2004
Review
2004
  • M. Bookman
  • 2004
  • Corpus ID: 38290730
Gemcitabine (2′2′-difluorodeoxycytidine [dFdC]) is a synthetic analog of deoxycytidine with two fluorine atoms at the 2′ position… 
Highly Cited
1997
Highly Cited
1997
Gemcitabine (2'2'-difluorodeoxycytidine, Gemzar) is a deoxycytidine analog with excellent antitumor activity against a number of… 
Review
1995
Review
1995
Gemcitabine (2I, 2I-difluorodeoxycytidine, dFdC) is a nucleoside analogue of deoxycytidine in which two fluorine atoms have been… 
Highly Cited
1995
Highly Cited
1995
Both gemcitabine (2',2'-difluorodeoxycytidine; dFdC) and cisplatin (cis-diammine dichloroplatinum; CDDP) are active against…